• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION SD 8120 ALARIS PCA; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION SD 8120 ALARIS PCA; PUMP, INFUSION Back to Search Results
Model Number 8120
Device Problems Computer Software Problem (1112); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Patient Involvement (2645)
Event Date 04/06/2018
Event Type  malfunction  
Manufacturer Narrative
The customer¿s experience of syringe volume discrepancies was not confirmed.The pcu event log shows the last infusion on pca module s/n (b)(4) was programmed at 4:20 pm on (b)(6) 2018.The user programmed a pca dose only infusion of hydromorphone 1:1 30mg in 30ml (drugid 226) using a 35ml monoject syringe with 28.8436ml detected.Each pca request delivered 0.15ml (later changed to 0.2ml).The infusion ran until the device was channeled off at 8:37 am on (b)(6) 2018.Between 4:21 pm on (b)(6) 2018 and 8:37 am on (b)(6) 2018, there were 51 delivered pca dose requests for a total of 10.1ml and 33 requests not delivered due to the lockout interval.A determination regarding syringe volume discrepancies due to the lack of information provided.A review of the device history record in sap for sn (b)(4) was performed from the date of the manufacture to date of the release of product, which confirmed that this device was not involved in a production failure, and product was not returned for servicing which correlates to the customer reported issue.A trackwise complaint history review was completed, and it was confirmed that there were additional complaints received with similar sn (b)(4) for the same or related failure mode.
 
Event Description
The customer is requesting assistance in determining the root cause for volume discrepancies found when administering hydromorphone 1mg/ml in 30ml with a demand dose 0.02mg every 10 minutes through the pca channel.Users have found a discrepancy between the remaining volume to be infused and the expected volume.There was no patient harm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
8120 ALARIS PCA
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer (Section G)
CAREFUSION SD
10020 pacific mesa blvd
san diego CA 92121 4386
Manufacturer Contact
suresh gokul selvaraj
10020 pacific mesa blvd
san diego, CA 92121-4386
8586172000
MDR Report Key10872770
MDR Text Key262880808
Report Number2016493-2020-38454
Device Sequence Number1
Product Code MEA
UDI-Device Identifier10885403812002
UDI-Public10885403812002
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K043299
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Reporter Occupation Nurse
Type of Report Initial
Report Date 06/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number8120
Device Catalogue Number8120
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/07/2011
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age47 YR
-
-